Cita APA

Albanell Mestres, J., Svedman, C., Gligorov, J., Holt, S. D., Bertelli, G., Blohmer, J., . . . Eiermann, W. (2016). Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancer.

Citación estilo Chicago

Albanell Mestres, Joan, Christer Svedman, Joseph Gligorov, Simon D.H Holt, Gianfilippo Bertelli, Jens-Uwe Blohmer, Roman Rouzier, Ana Lluch, y Wolfgang Eiermann. Pooled Analysis of Prospective European Studies Assessing the Impact of Using the 21-gene Recurrence Score Assay On Clinical Decision Making in Women With Oestrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Early-stage Breast Cancer. 2016.

Cita MLA

Albanell Mestres, Joan, et al. Pooled Analysis of Prospective European Studies Assessing the Impact of Using the 21-gene Recurrence Score Assay On Clinical Decision Making in Women With Oestrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Early-stage Breast Cancer. 2016.